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Bipolar disorder (BD) is a major psychiatric illness with a chronic recurrent course, 
ranked among the worldwide leading disabling diseases. Its pathophysiology is still not 
completely understood and findings are still inconclusive, though a great interest on the 
topic has been constantly raised by magnetic resonance imaging, genetic and neuro-
pathological studies. In recent years, diffusion tensor imaging (DTI) investigations have 
prompted interest in the key role of white matter (WM) abnormalities in BD. In this report, 
we summarize and comment recent findings from DTI studies in BD, reporting fractional 
anisotropy as putative measure of WM integrity, as well as recent data from neuropatho-
logical studies focusing on oligodendrocyte involvement in WM alterations in BD. DTI 
research indicates that BD is most commonly associated with a WM disruption within 
the fronto-limbic network, which may be accompanied by other WM changes spread 
throughout temporal and parietal regions. Neuropathological studies, mainly focused 
on the fronto-limbic network, have repeatedly shown a loss in cortical and subcortical 
oligodendrocyte cell count, although an increased subcortical oligodendrocyte density 
has been also documented suggesting a putative role in remyelination processes for 
oligodendrocytes in BD. According to our review, a greater integration between DTI and 
morphological findings is needed in order to elucidate processes affecting WM, either 
glial loss or myelin plasticity, on the basis of a more targeted research in BD.
Keywords: bipolar disorder, diffusion tensor imaging, myelin plasticity, oligodendrocyte, white matter disruption, 
connectivity
iNTRODUCTiON
Bipolar disorder (BD) is a major psychiatric illness that affects 1% of the population and has its onset 
during adolescence or early adulthood (1, 2). It significantly decreases the quality of life of patients 
and caregivers and increases the burden of health and social care services (3).
Since 90s, a growing interest on the neurobiological underpinnings of BD has been object of several 
magnetic resonance imaging (MRI) studies that, so far, have repeatedly reported diffuse white matter 
Abbreviations: ACC, anterior cingulate cortex; CC, corpus callosum; DLPFC, dorsolateral prefrontal cortex; GSK3β, glycogen 
synthase kinase 3beta; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; OD, oligodendrocyte 
density; OFC, orbitofrontal cortex; PFC, prefrontal cortex; sgACC, subgenual Anterior Cingulate Cortex; SLF, superior longi-
tudinal fasciculus.
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(WM) hyperintensities at T2-weighted sequences, spread out over 
subcortical, periventricular and callosal WM (4, 5). BD patients 
are 2.5 times more likely than healthy controls and 2 times more 
likely than depressed patients to show these neurobiological pro-
files, which have been therefore considered as a putative biological 
correlate of BD (5–7). Pieces of evidence suggested an association 
between more severe WM hyperintensities and poorer outcome 
measures, such as increased clinical severity (8), greater number 
of hospitalizations, poorer response to treatments (9) and higher 
suicide risk (10). Nevertheless, similar patterns of WM alterations 
did not seem to be specific to BD, as they have been found in 
neuropathological processes, such as cerebrovascular damage, 
astrocytic gliosis and demyelination processes (6).
A weakness of structural MRI in studying WM is the limited 
contrast detection in WM tracts, while diffusion tensor imag-
ing (DTI) is uniquely sensitive to WM microstructure analysis 
including axonal coherence, fiber density and myelin integity 
(11, 12). Since 2000s WM abnormalities in BD have been 
investigated using this imaging technique, which consists of a 
specific extension of MRI technology and allows a more precise 
identification of subtle WM derangements (13–15). Basically, 
DTI applies two indices for the study of WM’s physical integrity: 
the fractional anisotropy (FA) and the apparent diffusion coef-
ficient (ADC). FA measures the anisotropic diffusion of water 
molecules and ranges between 0 and 1. When water molecules 
diffuse along the neural fibers on their longitudinal axes, due to 
their directional movement constraint by thick myelin sheaths, 
FA is 1, whereas when water molecules diffuse toward random 
directions, following their Brownian motion, FA is 0. ADC is 
an index of the rate of water diffusion in cerebral tissues: higher 
values of ADC indicate less restricted diffusion; conversely, lower 
values of ADC point to the presence of organized fibers impeding 
water diffusion (16). To date, overall DTI findings in BD have 
reported either lower, higher or no difference  in FA between 
patients and healthy controls (12, 15, 17). Inconsistency across 
findings is supposed to reflect differences among DTI studies 
in data acquisition protocols as well as in patient characteristics 
(18). Most studies involve heterogeneous samples of BD patients 
combining subjects in different mood states (19), which could 
have different neural network activation correlates (20) and dif-
ferent WM DTI patterns (18, 21). Moreover, BD patients’ samples 
may differ for medication status (22), which could be considered 
as a relevant variable for interpreting findings. Indeed, lithium 
seems to act as a promyelinating factor (23, 24), whereas first 
and second generation antipsychotics are likely to impact on 
WM integrity, despite their effects vary markedly across studies 
ranging from promyelinating actions (24, 25) to impaired WM 
integrity (26).
The disruption of neural connectivity due to myelin sheath’s 
degradation, whose etiology is not yet fully understood, is sup-
posed to play a compelling role in the neurobiology of BD (7, 27). 
The molecular and cellular correlates of these structural MR and 
DTI findings have not been completely explained yet, although 
the role of glial cells has been implicated in the disruption of 
neural connectivity (28). In the human brain tissue, glial cells 
include oligodendrocytes (35%), oligodendrocytes progenitor 
cells (OPCs) (5%), astrocytes (45%) and microglia (5%) (24). 
A great amount of oligodendrocytes arise from the differentia-
tion of OPCs till the early postnatal period, yet to a lesser extent 
OPCs persist in generating oligodendrocytes during adulthood 
(29). Adult born oligodendrocytes might be involved in de novo 
myelination of previously naked or not completed myelinated 
axons, as well as in myelin remodeling that allows changes in 
existing myelin membrane sheaths in the central nervous system 
(CNS) (30, 31). Many DTI studies, genome wide association 
studies and postmortem studies have demonstrated that BD 
patients showed a reduction in myelin content in the CNS, 
especially in subcortical regions, along with aberrant expression 
of myelin-related genes and a reduction in oligodendrocyte cells’ 
count (32–34). These findings are pointing to the role of glial 
cells’ abnormalities in the disruption of WM connectivity in BD. 
However, a clear correlation between WM alterations in DTI 
studies and changes in glial cells’ population in neuropathologi-
cal studies is still lacking.
In this review, we address the issue of WM alterations in 
BD, based on the data from the most recent DTI studies, and 
we focus on oligodendrocyte involvement in WM alterations in 
BD, emphasizing the role of myelin plasticity on the basis of the 
available lines of evidence.
MATeRiALS AND MeTHODS
We carried out a literature search of published studies on the fol-
lowing databases: National Centre for Biotechnology Information 
(NCBI) PubMed (MEDLINE) and Google Scholar. We took into 
account published papers from August 2009 to August 2015 focus-
ing on the following key words: bipolar disorder, diffusion tensor 
imaging, white matter, myelin plasticity and oligodendrocytes. 
The reference lists of the included studies were then searched for 
additional studies.
Firstly, we only considered studies published in English with a 
patient population of 18–65 years old affected by BD, according 
to DSM-IV or ICD-10 criteria, where a DTI scan was performed. 
We limited our analysis to FA values, as other measures of dif-
fusivity, while potentially informative about WM impairments, 
were inconsistently applied across DTI studies. We included DTI 
studies applying either a region of interest (ROI)-based analysis 
or a whole brain analysis. Among whole brain DTI studies we 
used only voxel-based analysis (VBA) and tract-based spatial 
statistics (TBSS) analysis, excluding DTI tractography studies 
given that methodological issues are deemed to undermine a 
direct comparison between tractography and VBA approaches 
(35). Indeed, VBA images are smoothed and statistical thresholds 
are applied to generate a statistical map, where differences of 
voxel-wise mean values between groups are shown at a local level 
in brain regions, instead of tractography where DTI metric values 
are averaged along a 3-D ROI and local differences in specific 
regions of the reconstructed tract could be lost (35).The search of 
the literature revealed 88 publications suitable for the inclusion in 
the present paper, of these 13 were literature reviews and 2 were 
meta-analyses (see Table 1).
Secondly, we focused on studies published in English with a 
patient population of 18–65  years old affected by BD, accord-
ing to DSM-IV or ICD-10 criteria, where the oligodendrocyte 
TABLe 1 | Reviews and meta-analyses of diffusion tensor imaging studies investigating wM in patients with bipolar disorder.
Reference Metodology Subjects Main findings in BD patients
Teipel et al. 
(36)
Review of ROI studies and VBA 
studies
− ↓ FA in fronto-occipital and callosal connections, SLF, UF. ↓ FA right-sided in WM close to the PHG 
and sgACC
Dell’Osso et al. 
(37)
Review of ROI studies and VBA 
studies
− ↓ FA in WM of FC and OC, cingulum bundle, CC, internal capsule and FOF. ↓ FA right-sided in WM 
close to the PHG and sgACC. ↓ FA in ACR. ↑ FA in corticopontine/corticospinal tracts, SLF, TR
Marlinge et al. 
(38)
Review of ROI studies and VBA 
studies
− ↓ FA in CC, ACR, internal capsule and FOF. ↓ FA in WM close to right PHG (SLF, IFOF, ILF, PTR) 
and in WM close to right sgACC and right ACC
Hahn et al. (3) Review of ROI studies and VBA 
studies
271 BD pts 
vs. 108 HC
↓ FA in CC ventral part in late-life BD. No studies on WM alterations in late-onset BD
Shizukuishi 
et al. (39)
Review of ROI studies and 
TBSS studies
− ↓ FA in PF WM and ↑ FA in the genu of CC. ↑ FA in left UF and ↓ FA in right UF
Nortje et al. 
(40)
Review and meta-analysis of 
VBA studies and TBSS studies
252 BD pts 
vs. 256 HC
↓ FA in a right posterior tempo-parietal WM cluster and in two left cingulate WM clusters
Hafeman et al. 
(41)
Review of ROI studies and VBA 
studies
430 BD pts 
vs. 402 HC
↓ FA (especially in depressed patients) in CC, UF, SLF, anterior TR, ACB. Medicated BD pts more 
similar to HC than their unmedicated counterparts
Vederine et al. 
(42)
Review and meta-analysis of 
VBA studies
289 BD pts 
vs. 279 HC
↓ FA in a WM cluster close to right PHG (SLF, IFOF, ILF, posterior TR) and a WM cluster close right 
ACC and right sgACC
Bellani and 
Brambilla (18)
Review of ROI studies, VBA 
studies, TBSS studies
429 BD pts 
vs. 436 HC
↓ FA in SLF, FOF and CC
Mahon et al. 
(43)
Review of ROI studies, VBA 
studies, TBSS studies
524 BD pts 
vs. 561 HC
↓ FA along the UF and other WM tracts subserving both the OFC and the ACC as well as in TR 
fibers and SLF
Heng et al. (15) Review of ROI studies, VBA 
studies, TBSS studies
465 BD pts 
vs. 480 HC
↓ FA in PF WM. ↓ FA in projection, associative and commissural WM fibers
Palaniyappan 
et al. (44)
Review of ROI studies, VBA 
studies, TBSS studies
− ↓ FA in PF WM, ACB, temporal WM. ↑ FA in genu of CC. ↓ FA in UF, ACR, cingulate–amygdala–
hippocampal connections
Agarwal et al. 
(6)
Review of ROI studies and VBA 
studies
− ↓ FA in PF WM, CC and internal capsule
BD, bipolar disorder; WM, white matter; HC, healthy controls; DTI, diffusion tensor imaging; ROI, region of interest; VBA, voxel-based analysis; TBSS, tract-based spatial statistics; 
FA, fractional anisotropy; pts, patients; CC, corpus callosum; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; PHG, parahippocampal gyrus; sgACC, subgenual 
Anterior Cingulate Cortex; ACC, anterior cingulate cortex; FC, frontal cortex; OC, occipital cortex; FOF, fronto-occipital fasciculus; ACR, anterior corona radiata, TR, thalamic 
radiation; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; PTR, posterior thalamic radiation; PF, prefrontal; OFC, orbitofrontal cortex; OF, orbitofrontal; 
ACR, anterior corona radiata, ACB, anterior cingulum bundle.
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involvement was specifically addressed at a neuropathological 
level. We included studies focused on perineuronal and myelinat-
ing oligodendrocytes because oligodendrocytes exist both in GM 
and WM and alterations in GM glial organization are thought 
to be related to WM changes (43). We excluded and considered 
unfocused all the studies investigating glial cells without consid-
ering oligodendrocyte density (OD) in BD patients and controls. 
Eight studies identified by the literature search were judged to 
fulfill these inclusion criteria (see Table 2).
ReSULTS AND DiSCUSSiON
Several structural MRI studies, using both ROI analysis and 
VBA, indicated that WM hyperintensities, especially in the 
prefrontal and frontal WM, were associated with BD compared 
with healthy controls (4, 43). These WM abnormalities’ observa-
tions have been replicated in studies on first-episode BD patients 
(51) and adolescents with BD (52, 53). All together, these studies 
suggested that, besides confounders as brain aging and medical 
illnesses, other processes should be involved in the pathophysi-
ology of BD.
Diffusion tensor imaging provides a more sensitive tool, 
compared to structural MRI, to investigate WM integrity and 
microstructure (11, 12). In the following paragraphs, DTI studies 
accordingly to the different methodological approaches  –  ROI 
analysis, VBA and TBSS analysis – will be briefly debated.
ROi-Based Analysis
Most of DTI studies based on ROI approach showed lower FA 
among BD patients compared with healthy controls, mainly in 
WM tracts in prefrontal areas, anterior cingulum, callosal areas, 
and limbic-striatal areas (54–56). These abnormalities, particu-
larly in deep prefrontal WM, have been reported since the first 
episode of mania (14). In support of these findings, a review of 
ROI-based studies has recently confirmed a loss of bundle coher-
ence and alignment of WM fibers in the following areas in BD: 
deep WM in frontal and occipital lobes, anterior cingulum, corpus 
callosum (CC), anterior corona radiata and internal capsule (38). 
TABLe 2 | Neuropathological postmortem studies focusing on oligodendrocyte involvement in bipolar disorder.
Reference Methodology Subjects Age, years 
(mean ± SD)
Sex ratio 
M/F
Main findings
Hercher 
et al. (28)
Neuropathological postmortem 
assessment of DLPC WM in SZ, BD, 
and HC (2-D cell counting technique)
20 SZ vs. 20 BD 
vs. 20 HC
SZ 44.7 (±6.9), BD 47.4 
(±0.7), HC 45 (±6.5)
SZ 13/7, BD 
8/12, HC 
14/6
↑ OD in BD vs. HC. No differences in SZ vs. 
HC. No differences in AD among the groups 
just a trend toward ↓ AD in SZ vs. HC
Savitz et al. 
(45)
Review of postmortem studies on 
mPFC neuronal density and glial cell 
density in BD and HC
− − − 3-D cell counting studies:↓ glial cell density 
(predominantly ↓ OD) in BD vs. HC. Unclear if 
↓ ND in BD vs. HC
Haroutunian 
et al. (46)
Review of postmortem studies 
and genetic studies on myelin and 
oligodendrocyte involvement in SZ, BD, 
and MDD
− − − ↓ cortical OD and myelin gene disruption in 
SZ, BD and MDD vs. HC. ↓ subcortical OD in 
BD and MDD vs. SZ
Williams 
et al. (47)
Neuropathological postmortem 
assessment in sgACC and genu of CC 
among SZ, BD, MDD, and HC (2-D cell 
counting technique)
10 SZ vs. 15 BD 
vs. 20 MDD vs. 
19 HC
SZ 65.5 (±2.3), BD 56.1 
(±5.2), MDD 47.6 (±3.1), 
HC 65.5 (±2.3)
SZ 5/5, BD 
6/9, MDD 
7/13, HC 
11/8
↓ AD in sgACC and anterior CC WM in SZ 
vs. HC. No changes in OD among different 
groups in sgACC and anterior CC WM
Gos et al. 
(48)
Neuropathological postmortem 
assessment of AD and OD in HPC 
(alveus and CA1 pyramidal layer) 
among MDD, BD, and HC (2-D cell 
counting technique)
6 BD vs. 9 MDD 
vs. 13 HC
BD 55.7 (±13.3), MDD 
49.6 (±11), HC 55.3 
(±12.3)
BD 3/3, 
MDD 2/7, 
HC 7/5
Bilateral ↓ AD in CA1 pyramidal layer in MDD 
and BD vs. HC. ↓ OD in left alveus only in BD 
vs. HC
Hayashi 
et al. (49)
Neuropathological postmortem 
assessment of PFC and ITC GM to 
examine OD among SZ, BD, and HC 
(3-D cell counting technique)
10 PFC SZ vs. 12 
PFC BD vs. 12 
PFC HC 11 ITC SZ 
vs. 11 ITC BD vs. 
11 ITC HC
PFC SZ 43 (±14), BD 
41 (±11), HC 48 (±11) 
ITC SZ 45 (±14), BD 41 
(±12), HC 50 (±10)
PFC: SZ 7/3, 
BD 7/5, HC 
8/4 ITC: SZ 
6/5, BD 6/5, 
HC 7/5
↓ OD in PFC GM of BD vs. SZ and HC. ↓ ID in 
ITC GM of BD and SZ vs. HC
Mahon et al. 
(43)
Review of postmortem neuroimaging 
and genetic studies on WM in BD
− − − 3-D cell counting studies: ↓ cortical OD in 
sgACC and DLPC in BD vs. HC. Disruption 
in myelin and oligodendrocyte-related genes 
expression in BD
Vostrikov 
et al. (50)
Neuropathological postmortem 
assessment of OD related to age in 
PFC among SZ, MDD, BD, and HC 
(2-D cell counting technique)
15 SZ vs. 15 BD 
vs. 15 MDD vs. 
15 HC
SZ 44.5 (±13.1), BD 
42.3 (±11.7), MDD 46.5 
(±9.3), HC 48.1 (±10.7)
SZ 9/6, BD 
9/6, MDD 
9/6, HC 9/6
↓ OD in young BD vs. HC. Age-related ↑ OD in 
HC, but not in SZ, MDD, and BD
SZ, schizophrenia; BD, bipolar disorder; MDD, major depressive disorder; HC, healthy controls; pts, patients; GM, gray matter; WM, white matter; DLPFC, dorso lateral prefrontal 
cortex; OD, oligodencrocyte density; ID, interneuron density; AD, astrocyte density; ND, neuronal density; sgACC, subgenual Anterior Cingulate Cortex; CC, corpus callosum; HPC, 
hippocampus; ITC, inferior temporal cortex.
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Though consistent and replicated, these results might be limited 
by a selection bias, as ROI-based approach is hypothesis-driven 
and provides information only about selected brain regions.
voxel-Based Analysis
Voxel-based analysis allows DTI data analysis over the whole 
brain volume without a priori hypotheses on specific regions of 
interest, thus overcoming possible selection bias from the ROI 
approach.
The current findings from VBA-DTI studies suggest the exist-
ence of diffuse WM microstructural abnormalities as BD’s trait 
feature, raising the intriguing notion of a disconnected frame-
work within fronto-limbic areas as well as between fronto-limbic 
and temporal, parietal and occipital lobes. A recent meta-analysis 
(40) showed decreased FA in all major classes of WM tracts (i.e., 
commissural, association and projection), with more robust 
findings on Bipolar Type 1 vs. Bipolar Type 2 patients. VBA 
data displayed significant clusters of decreased FA within right 
temporo-parietal WM, involving both inferior fronto-occipital 
fasciculus (IFOF) and inferior longitudinal fasciculus (ILF), left 
cingulum and left anterior cingulate. These findings suggest a 
wide alteration in the WM of CNS in BD, which involves not 
only an anterior fronto-limbic pathway but also fibers connecting 
temporal and parietal cortices. Consistent with these observa-
tions, a recent integrated structural MRI/DTI study (57) found a 
global reduction of WM volume and WM clusters of decreased 
FA in BD patients, ranging from prefrontal WM to the splenium 
of CC and posterior cingulum bundle. Additionally, the authors 
also investigated whether pharmacological treatment could 
have influenced their findings and they observed no significant 
association between lithium medication and any DTI measures, 
while total GM volume was increased with significant clusters 
in temporal lobes in patients treated with lithium. Moreover, 
a meta-analysis of VBA-DTI studies in BD (38) found two 
consistent clusters of FA and mean diffusivity alterations both 
of them located in areas relevant for emotional processing in 
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the right hemisphere. The first cluster was close to the right 
parahippocampal gyrus in a WM area crossed by the superior 
longitudinal fasciculus (SLF), ILF, IFOF and posterior thalamic 
radiations, while the second one was close to the right anterior 
cingulate cortex (ACC) and the right subgenual cingulate cortex 
(sgACC). These findings prompted the authors to speculate that 
a pattern of disrupted WM connectivity may underlie the abnor-
mal emotional processing in BD patients compared with healthy 
controls. It is worth highlighting that a disruption of SLF might 
contribute to fronto-temporal disconnection, which could be rel-
evant to emotional cognitive modulation and inhibition, whereas 
the disruption of ILF and IFOF could underlie facial emotion 
recognition deficits, proposed as a potential endophenotype for 
BD (58, 59). Furthermore, both ACC and sgACC are thought 
to be involved in identification of emotionally salient stimuli 
and WM diffusion abnormalities, clustered close to these areas, 
have been associated with dysfunctional emotional processes in 
BD (60). Indeed, a disrupted WM connectivity between these 
regions and a dorsal cognitive network [dorsolateral prefrontal 
cortex (DLPFC), dorsal cingulate cortex, precuneus, cuneus] is 
supposed to play a role in over reactivity of ACC and sgACC 
during emotional processing in bipolar patients (61).
White matter microstructure changes have been also regarded 
as a possible DTI endophenotypic marker in BD. Interestingly, a 
VBA-DTI study comparing individuals with BD, their ultra-risk 
(UR) relatives and healthy controls found no significant FA dif-
ferences in UR vs. healthy controls (62). However, the post hoc 
analysis, including the density of illness within families, revealed 
a reduction in FA associated with increasing genetic liability in 
prefrontal WM, SLF, CC and uncinate fasciculus. Furthermore, 
a lower FA in SLF has been reported in children at risk of BD in 
a study comparing children at risk of BD with a sample of unaf-
fected children (63).
Eventually, the notion of early WM markers of vulnerability 
for BD has been recently strengthened by a review of DTI studies 
in BD children and adolescents (2). In keeping with VBA-DTI 
findings in adults with BD, the study reported that BD children 
and adolescents showed a pattern of decreased FA both in fronto-
temporal intrahemispheric WM (prefrontal WM, cingulum 
bundle, WM bundles to dorsal frontal regions, basal ganglia, 
thalamus and posterior association cortices) and fronto-temporal 
interhemispheric WM (anterior CC).
Tract-Based Spatial Statistics Analysis
Tract-based spatial statistics analysis is a whole brain analysis of 
DTI data, which focuses on the centers of all fiber bundles, improv-
ing the probability that the given space voxels contain uniform 
data from the same WM tract (the most compact WM skeleton). 
TBSS approach overcomes the misinterpretation of crossing 
fibers areas hindering the reliability of traditional voxel-wise 
analysis (64).
Significant widespread decreases in FA have been predomi-
nantly reported so far by TBSS DTI studies among BD patients 
compared with healthy controls with WM changes encompass-
ing all major WM tracts (projection, association, callosal and 
limbic fibers). Indeed, in a recent published meta-analysis of 
TBSS studies, Nortje and colleagues (40) showed a decreased 
FA in all main classes of WM tracts, though the pattern of 
mostly involved bundles was different among independent 
studies. Consistent with these results, a TBSS study, employ-
ing a group of bipolar I and II patients in comparison with a 
group of healthy controls, reported in BD patients a significant 
lower FA in CC, cingulum bundles, fornices, SLF, ILF, fronto-
occipital fasciculus, thalamic radiation and uncinate fasciculus 
(65). These widespread WM diffusion abnormalities, including 
fronto-temporal and ventral striatal regions, were marked 
by significant differences in diffusivity measures other than 
FA, leading the authors to conclude that dysmyelination and 
demyelination rather than axonal loss are implicated in BD 
(66, 67). Providing further support to these lines of evidence, 
a TBSS study considering 40 inpatients with bipolar depression 
vs. 21 healthy controls showed a reduced FA in the following 
WM areas: CC, cingulum, corona radiata and SLF (68). The 
authors considered the disrupted connectivity evidenced in 
interhemispheric connections as well as in frontal, parietal and 
fronto-occipital connections as the biological underpinning of 
cognitive and emotional deficits of bipolar depression. Notably, 
in this study, lower FA values were coupled with higher radial 
diffusivity and mean diffusivity with no differences in parallel 
diffusivity, consistently with those findings showing a disrup-
tion in myelin sheaths without axonal loss (69).
Finally, DTI measures have been also investigated as biomark-
ers of treatment response, even though robust evidence on this 
subject is still missing with studies focusing mostly on major 
depressive disorder (70, 71). To the best of our knowledge, the 
role of WM microstructure in predicting treatment efficacy in BD 
has been investigated in just one TBSS DTI study (72). Authors 
revealed a significant association between poor response to 
chronotherapeutic treatment in bipolar depression and increased 
radial diffusivity and mean diffusivity in WM tracts involved in 
cognitive and emotional deficits (CC, cingulum bundle, IFOF, 
SLF, corona radiata and anterior thalamic radiation).
Unfortunately, DTI measures, regardless of which approach 
is applied, are relatively non-specific and do not clearly differ-
entiate between axon and myelin-based abnormalities (73). As 
outlined in a recently published study (74), DTI quantifies dif-
fusion of water molecules and water exists in both intracellular 
and extracellular spaces (with exchange between two). Thus, the 
authors applied a more refined MRI approach, using magnetiza-
tion transfer ratio, in order to study myelin content, and diffusion 
tensor spectroscopy, in order to study N-acetylaspartate diffusion 
within axons. Their results showed reduced myelin content but no 
changes in intra-axonal geometry, considered as a proxy of axonal 
integrity, in patients with BD vs. healthy controls. Furthermore, 
axonal demyelination is just one of several possible factors 
impacting on FA values, including bundle coherence, crossing 
fibers, water concentration and neuronal loss (13). Therefore, 
findings of abnormal FA in either direction that are not supported 
or followed up by neuropathological postmortem investigations 
should be interpreted with caution (43).
Myelin Plasticity
In humans, developmental myelination is a long-lasting process 
continuing at least until the fourth decade of life (75, 76) and 
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proceeding in predictable spatial and temporal patterns (i.e., 
thicker axons are myelinated before thinner axons, brain regions 
devoted to more basic and homeostatic functions, such as brain-
stem, are myelinated before high level integrative areas, such as 
cortical association fibers) (77). During and even after the devel-
opmental myelination, mammalian CNS myelin has shown to be 
plastic and sensitive to experience dependent structural changes: 
this feature is referred to as myelin plasticity (78).
So far, postmortem studies of individuals with BD have shown 
sparse and contradictory findings about WM and GM changes in 
number, size and density of different glial cell populations (43, 46, 
49). As regards the oligodendrocytes involvement, evidence from 
several morphometric postmortem studies, identified in our lit-
erature search, pointed out that BD patients might be affected by 
an oligodendrocyte cell loss in the same areas where DTI studies 
have reported WM diffusivity abnormalities. Indeed, lending 
support to this speculation, a review of postmortem neuropatho-
logical studies, focusing on medial prefrontal cortex (mPFC) 
network in BD patients, has recently reported a reduction in glial 
cells both in sgACC and DLPFC (45). Both perineuronal and 
myelinating oligodendroglia cells were the most clearly involved 
glial cell populations. Interestingly, the oligodendroglia cell loss 
in BD was correlated with a putative increase of neuronal density 
in sgACC, orbitofrontal cortex (OFC) and DLPFC due to den-
dritic atrophy (the great amount of GM consisting of neuropil). 
Furthermore, a neuropathological study (48) evaluating astro and 
oligodendroglial expression of SB100 (a glial marker protein), in 
CA1 pyramidal layer and the alveus of hippocampus, showed a 
decreased OD in BD compared with healthy controls in the left 
alveus. Congruent with these neuropathological observations, 
many genetic studies, which support the role of oligodendrocyte 
dysfunction in BD, reported a downregulation of key oligoden-
drocyte and myelination genes in BD compared with healthy 
controls (20, 24, 79, 80). Notably, Tkachev and colleagues (81) 
provided a strong evidence for a downregulation of key oligoden-
drocyte and myelination genes, including transcription factors 
that regulate these genes, in bipolar and schizophrenic patients 
compared with healthy controls, by using quantitative polymer-
ase chain reaction and microarray analysis. A selective reduction 
in oligodendrocyte-related gene expression was noted, after con-
trolling for confounding variables such as medication and alcohol 
abuse, pointing toward a cellular dysfunction or death. Even if 
there are not conclusive evidences, the mechanism underlying an 
oligodendroglia cell loss is likely to affect inhibitory GABAergic 
transmission: a GABAergic interneuron loss, which decreases 
the inhibitory feedback on glutamatergic neurons, may lead to 
excitotoxicity-induced dendritic atrophy and/or oligodendrocyte 
cell loss (82). As known, oligodendrocytes express AMPA and 
kainate-type glutamate receptors, therefore they are highly sensi-
tive to excitotoxic damage from an excessive glutamate-mediated 
activation (83, 84).
However, in contrast to the evidence for an oligodedroglia 
cell loss, a recent study investigating the morphological basis 
underlying WM alterations located in DLPFC in bipolar and 
schizophrenia patients showed an increased OD in the BD 
group compared both with schizophrenia and healthy control 
subjects (28). It is worth noting that the increased OD in the 
subcortical WM of DLPFC was not correlated with higher 
myelin content, as evidenced by the increase of a marker protein 
located in oligodendrocyte cell bodies (2′3′ cyclic 3′phos-
phodiesterase) and no changes in a marker protein located 
in compact myelin (myelin basic protein). These findings are 
very intriguing as, along with the observation of an increased 
myelin peroxidation in the myelin fraction in BD patients (85), 
they strengthen the hypothesis that an increased OD could 
reflect a compensatory mechanism of repairing damage. In this 
perspective, the proliferation and differentiation of OPCs into 
mature oligodendrocytes could play a role in replacing damaged 
myelin throughout a remyelination process in the adult brain. 
With regard to the putative compensatory mechanism to restore 
damaged myelin, Bartzokis (24) has mainly shifted the emphasis 
from subcortical into intracortical myelination processes as key 
factor in better understanding BD’s pathophysiology. In the 
human brain development, during childhood the subcortical 
WM myelination would achieve a network of axons’ synchro-
nization, connecting widely distributed brain regions, whereas 
throughout adulthood the intracortical myelination would 
make faster and more synchronized this transmission, by adding 
further myelin sheath. Intracortical myelin could compensate 
for a disruption in transmission along WM subcortical fibers, 
due to either subcortical myelin damages or subcortical remyeli-
nation processes which produce thinner myelin sheaths. These 
events could influence the quality of neurotransmission as the 
thickness of myelin sheaths is inversely correlated with speed of 
conduction and network synchronization (19). If an adequate 
intracortical myelin plasticity may initially compensate for sub-
cortical transmission delays, during the course of the illness an 
increasing intracortical myelin disruption could undermine this 
compensation mechanism and thus give raise to an increasingly 
disrupted WM connectivity (24). At the onset of BD, subcortical 
myelin deficits seem to be more prominent than intracortical 
myelin deficits (86) but, during the course of the illness, signifi-
cant intracortical oligodendrocyte deficits develop in BD (50) 
while cognitive deficits worsen (87, 88). Noteworthily, converg-
ing evidence of a decreased OD in the gray matter of DLFC and 
sgACC in BD, as compared to healthy controls, has been raised 
by several reviews of morphometric studies (43, 45), though 
not homogeneous in terms of cell counting technique applied 
(either 2-dimensional or 3-dimensional). Furthermore, a study 
(49) applying a 3-dimensional cell counting method confirmed 
the existence of a significantly decreased intracortical OD in the 
PFC of BD patients as compared not only to healthy controls 
but also to SZ patients, thus suggesting this neuropathological 
abnormality as more commonly associated to BD than SZ. 
Eventually, it is of interest to mention that another study (50) 
reported a reduction of OD in PFC of BD patients along with a 
loss of age-related increase in OD of either BD or SZ or MDD 
patients in layer VI of the PFC (BA 9) as compared to controls. 
These findings led the authors to postulate that common age-
related process of OD increase is dysregulated in SZ and mood 
disorders. Taken together, these findings are consistent with a 
oligodendrocyte cell loss affecting the intracortical myelination 
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within the fronto-limbic network in BD, whereas direct evidence 
from human neuropathological studies for the role of myelin 
plasticity in BD is still missing.
It should be noted that neuropathological results regarding 
WM alterations in BD are limited by several key factors listed/
described as follows (89, 90): they are prominently focused on 
prefrontal WM and show heterogeneous and quite inconsistent 
findings; there are wide discrepancies between the 2-D vs. 3-D 
counting methods, given that caution must be taken particu-
larly with 2-D counting methods, which have a higher risk 
of sampling bias than methods which involve a stereological 
approach (91); many histological variables can bias the results 
impacting on postmortem tissue such as longer fixation time, 
increased pH and post-mortem interval; psychiatric medica-
tion, non-prescription drugs and substance abuse (especially 
alcohol abuse) should be taken into account as possible 
confounding factors, especially because the lifetime exposure 
can alter brain biology. As far as psychotropic treatment in 
BD is concerned, both mood stabilizers and antipsychotics 
may drive promyelinating effects working on the inhibition 
of glycogen synthase kinase 3beta (GSK3β) throughout differ-
ent biochemical pathways (38, 46). Lithium seems to mainly 
target subcortical WM throughout the GSK3β inhibition both 
directly via competition with magnesium and indirectly by 
increasing serine-phorphorylation of GSK3 through AKT (a 
serine/threonine kinase) activation (92), whereas first and sec-
ond generation antipsychotics have been reported to promote 
predominantly intracortical myelination by inhibiting GSK3 
signaling via dopamine 2 receptor blockade and 5HT2A recep-
tor blockade (93).
Finally, oligodendrocyte alterations are not limited to BD but 
encompass most psychiatric conditions including major depres-
sion disorder, schizophrenia, attention-deficit and hyperactivity 
disorder and Alzheimer’s disease (94). The essential mechanism 
underling these alterations remains partially unknown; however, 
most of the current models point to a stress-related vulnerability 
mechanism prompted by disturbances in chromatin regulation, 
glutamate-mediated excitoxicity and glucocorticoid mechanism 
(95): a deficit/dysfunction in oligodendrocytes population could 
disrupt WM connectivity, affecting the trophic axonal sup-
port and thus determining a suboptimal conduction of action 
potentials.
CONCLUSiON
So far, DTI studies have consistently shown an alteration in pre-
frontal–limbic anatomical connectivity, leading to the hypothesis 
of BD as a connectivity disorder. Accordingly to this hypothesis, 
prefrontal regions would fail to regulate limbic regions, triggering 
emotional hyper reactivity and emotional instability. Besides this 
core and more consistent feature, rising lines of evidence are con-
sidering temporo-parietal WM abnormalities of long association 
tracts as a structural background of cognitive rather than affective 
symptoms in BD.
Although DTI studies provided compelling findings, some 
inaccuracies remain in the current DTI technique (18, 40, 68): 
clusters of WM alterations do not delineate tidily and WM tracts 
have an interindividual variability making it unclear which tracts 
are involved; WM microstructure may be affected by age, sub-
stance use, lithium use, antipsychotic use and genetic loading for 
BD; eventually, there are often differences among study popula-
tions with regard to bipolar subtype, affective state, duration of 
illness, medication status, comorbidities and family history.
Furthermore, morphological studies with larger and more 
homogeneous samples are required to clarify oligodendrocytes 
dysfunctions as well as to investigate the possible role of cortical 
and subcortical myelin plasticity in BD. In this regard, postmor-
tem studies should have a key role to refine DTI studies’ results. 
Indeed, it should be clearly kept in mind that any inference on tis-
sue microstructure arising from DTI data is based on an indirect 
measurement “prior to making bold claims about white matter 
integrity” (96).
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